Biogen (BIIB) Net Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Biogen (BIIB) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.54 Bn | 193.55 Bn | 7.24 Bn | 802.00 |
| 2 | Gilead Sciences | 180.79 Bn | 177.62 Bn | 6.22 Bn | -16,220.00 |
| 3 | Vertex Pharmaceuticals | 131.64 Bn | 123.79 Bn | 2.84 Bn | -185.00 |
| 4 | Regeneron Pharmaceuticals | 81.93 Bn | 73.93 Bn | 3.93 Bn | -763.00 |
| 5 | Argenx Se | 61.25 Bn | 56.06 Bn | 1.37 Bn | 529.00 |
| 6 | Moderna | 55.42 Bn | 50.28 Bn | 52.00 Mn | 4,168.00 |
| 7 | Alnylam Pharmaceuticals | 33.27 Bn | 29.97 Bn | 992.69 Mn | 2,208.00 |
| 8 | Biogen | 31.98 Bn | 30.69 Bn | 1.96 Bn | -2,043.00 |
| 9 | Roivant Sciences | 29.95 Bn | 29.95 Bn | 1.16 Mn | -753,036.00 |
| 10 | Insmed | 28.05 Bn | 26.89 Bn | 358.27 Mn | 29,636.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,043.00 |
| Mar 31, 2026 | 300.00 |
| Dec 31, 2025 | -1,301.00 |
| Sep 30, 2025 | 265.00 |
| Jun 30, 2025 | 32.00 |
| Mar 31, 2025 | -728.00 |
| Dec 31, 2024 | 43.00 |
| Sep 30, 2024 | 1,845.00 |
| Jun 30, 2024 | -48.00 |
| Mar 31, 2024 | 144.00 |
| Dec 31, 2023 | -1,117.00 |
| Sep 30, 2023 | -4,794.00 |
| Jun 30, 2023 | -1,651.00 |
| Mar 31, 2023 | 698.00 |
| Dec 31, 2022 | 2,300.00 |
| Sep 30, 2022 | 3,383.00 |
| Jun 30, 2022 | 494.00 |
| Mar 31, 2022 | -693.00 |
| Dec 31, 2021 | -1,330.00 |
| Sep 30, 2021 | -983.00 |